"You decide and we provide."
Cart 0

BRIEF-Immune receives nasdaq letter

reutersCOMPANYNEWS companyNews

* Got notice from listing qualifications department of Nasdaq notifying that Co does not comply with Nasdaq's filing requirements Source text for Eikon: Further company coverage:

Older Post Newer Post

Leave a comment

Please note, comments must be approved before they are published